CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 950 participants.

Also called NCT02579096

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 950 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02579096
Other papers using this trial's data
  • Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout Arthritis & rheumatology (Hoboken, N.J.), 2024-04 DOI, PubMed 37842953, PMC10965366 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators Scientific reports, 2024-10-19 DOI, PubMed 39426967, PMC11490615 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02579096. Randomized; quadruple masking; primary purpose treatment. Start 2017-03-06 (actual); primary completion 2021-02-01 (actual). Results posted on 2022-01-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
Condition
Gout
Condition
Chronic Kidney Diseases
Intervention (Drug)
allopurinol capsule, 100-800 mg by mouth once daily
Intervention (Drug)
febuxostat tablet 40-120 mg by mouth once daily
Intervention (Drug)
Placebo, vehicle control (febuxostat-shaped)
Intervention (Drug)
Placebo, vehicle control (allopurinol-shaped)
Lead sponsor
VA Office of Research and Development (class: US federal agency)

Record details

Record id
cardio:ct-nct02579096
Content hash
09e9053fa47d311e59c61bd72d478f499c22fcc702a1cf72af6362a99b1a68be